Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoya Maeda

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
European Journal of Haematology|December 19, 2015
Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remissionMasamitsu Yanada, Junya Kanda, Shigeki Ohtake, et al.
Cancer|June 27, 2013
The demarcation between younger and older acute myeloid leukemia patients: a pooled analysis of 3 prospective studiesMasamitsu Yanada, Shigeki Ohtake, Shuichi Miyawaki, et al.
Annals of Hematology|April 26, 2018
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALLYoshihiro Hatta, Shuichi Mizuta, Keitaro Matsuo, et al.
Hemasphere|July 21, 2023
High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT StudySatoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, et al.
Cancer Science|May 12, 2020
Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3-internal tandem duplication AML: The JALSG AML209-FLT3-SCT studyNaomi Kawashima, Yuichi Ishikawa, Yoshiko Atsuta, et al.
Leukemia Research|June 20, 2018
Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: From the Japanese central review studyAkira Matsuda, Hiroshi Kawabata, Kaoru Tohyama, et al.
International Journal of Hematology|August 27, 2025
Dasatinib is superior to imatinib in adult Ph + ALL: a propensity score-matched analysis of pooled JALSG trial dataSatoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, et al.
Annals of Hematology|November 8, 2023
Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCTNoriharu Nakagawa, Ken Ishiyama, Kensuke Usuki, et al.
British Journal of Haematology|January 31, 2024
Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registryTomoya Maeda, Akira Matsuda, Junya Kanda, et al.
British Journal of Haematology|April 22, 2025
Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasmsTomoya Maeda, Akira Matsuda, Junya Kanda, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
European Journal of Haematology|December 19, 2015
Unrelated bone marrow transplantation or immediate umbilical cord blood transplantation for patients with acute myeloid leukemia in first complete remissionMasamitsu Yanada, Junya Kanda, Shigeki Ohtake, et al.
Cancer|June 27, 2013
The demarcation between younger and older acute myeloid leukemia patients: a pooled analysis of 3 prospective studiesMasamitsu Yanada, Shigeki Ohtake, Shuichi Miyawaki, et al.
Annals of Hematology|April 26, 2018
Final analysis of the JALSG Ph+ALL202 study: tyrosine kinase inhibitor-combined chemotherapy for Ph+ALLYoshihiro Hatta, Shuichi Mizuta, Keitaro Matsuo, et al.
Hemasphere|July 21, 2023
High-risk Combinations of Additional Chromosomal Abnormalities in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia: JALSG Ph+ALL TKI-SCT StudySatoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, et al.
Cancer Science|May 12, 2020
Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3-internal tandem duplication AML: The JALSG AML209-FLT3-SCT studyNaomi Kawashima, Yuichi Ishikawa, Yoshiko Atsuta, et al.
Leukemia Research|June 20, 2018
Interobserver concordance of assessments of dysplasia and blast counts for the diagnosis of patients with cytopenia: From the Japanese central review studyAkira Matsuda, Hiroshi Kawabata, Kaoru Tohyama, et al.
International Journal of Hematology|August 27, 2025
Dasatinib is superior to imatinib in adult Ph + ALL: a propensity score-matched analysis of pooled JALSG trial dataSatoshi Nishiwaki, Isamu Sugiura, Shin Fujisawa, et al.
Annals of Hematology|November 8, 2023
Outcomes of transplant-eligible patients with myelodysplastic syndrome with excess blasts registered in an observational study: The JALSG-CS11-MDS-SCTNoriharu Nakagawa, Ken Ishiyama, Kensuke Usuki, et al.
British Journal of Haematology|January 31, 2024
Clinical impact and characteristics of erythroid dysplasia in adult aplastic anaemia: Results from a multicentre registryTomoya Maeda, Akira Matsuda, Junya Kanda, et al.
British Journal of Haematology|April 22, 2025
Comparison of severe aplastic anaemia and lower risk hypoplastic myelodysplastic neoplasms: Critical role of megakaryocyte count in distinguishing aplastic anaemia from myelodysplastic neoplasmsTomoya Maeda, Akira Matsuda, Junya Kanda, et al.
Pageof 9